A founding doctor of a California gender medical treatment facility for children took thousands of dollars in consulting fees from big pharma companies that manufacture and sell puberty-blocking drugs.
Dr. Stephen Rosenthal is the medical director for the University of California San Francisco Benioff Children’s Hospital “Child and Adolescent Gender Center.” He is also a co-founder of the center.
According to reporting by Breitbart News, Rosenthal received payments from multiple pharmaceutical companies that make money off of the sale of puberty blockers. A report from Care Dash, a review site that analyzes compensation paid to healthcare providers, shows that Rosenthal received more consulting payments than 98% of American endocrinologists.
Between 2015 and 2021, Rosenthal accepted $31,282 from three large pharmaceutical firms in consulting fees.
In particular, he was paid $14,335 by Hexal regarding its drug Omnitrope. That medication assists in the conversion of testosterone to estrogen.
He took $11,503 from AbbVie for consulting regarding the off-label puberty blocker Lupron. The company sells the drug for almost $2,000 for a one-month supply. The potent medication has been used to chemically castrate sex offenders.
He was also paid $5,444 by Endo Pharmaceuticals regarding its puberty-blocking drug Supprelin LA.
In 2018, Rosenthal was the third-highest compensated doctor in the nation related to Supprelin LA and the fifth-highest related to Omnitrope.
Endo Pharmaceuticals and AbbVie are now under investigation by Texas Attorney General Ken Paxton. Both companies have allegedly advertised and promoted their puberty-blocking drugs for uses that are not approved by the Food and Drug Administration (FDA). They are also claimed to have failed to disclose the risks associated with the drugs to parents and children.
In his position as director of the Child and Adolescent Gender Center, Rosenthal publicly advocates for “gender-affirming care” for minors. In a recent interview with PBS, he said that providing kids with “cross-sex hormones” reduces childhood depression and suicidal ideations.
Rosenthal’s center advertises itself as a provider of “advocacy and legal support” for kids who are “transgender, nonbinary and gender-expansive.” It claims that its treatments are “fully reversible” and help children to reach “greater self-awareness of their gender identity.”